Newsroom

Sundheim Family’s Gift Ignites Hope for Diabetes Cure

MIAMI (Feb. 6, 2024) – Dan and Brett Sundheim, through the Sundheim Family Foundation, continue their efforts to transform the healthcare landscape for patients navigating type 1 diabetes through a $1 million gift to the Diabetes Research Institute (DRI), a global leader in diabetes research and care whose mission is to discover a cure for diabetes.

Dan, the founder of D1 Capital Partners, along with his wife Brett, who together are notable philanthropists, have invested in DRI’s mission to alleviate the burden of this chronic and prevalent disease. It is also personal; the family has been directly affected by type 1 diabetes.

“When we moved to Miami from New York, we were eager to continue our support of the Diabetes Research Institute, which is laser-focused on finding a cure,” said Brett. “My family is one among millions worldwide who are impacted every day by this disease. We are confident that our philanthropic investment in the DRI will accelerate innovative research that will hopefully one day end diabetes as we know it.  We invite everyone to become involved in whatever way they can to help advance the DRI mission.“

“We are very thankful to the Sundheims for their deep commitment to finding a cure for diabetes. Their generous gift will help us push the boundaries of scientific knowledge and bring us closer to a world free of diabetes,” said Matthias von Herrath, Scientific Director of the DRI.

Added Michael Burton, Chief Executive Officer of the DRI Foundation: “The Sundheims’ philanthropic leadership serves as an inspiration for others to join our cause, underscoring the importance of strategic philanthropy in driving innovation in healthcare and improving the lives of those affected by diabetes.”

Be Part of the Cure

The DRI has made tremendous headway in finding the cure for diabetes. Recent advances include the development of more tolerable combination therapies to enhance the survival and function of transplanted, insulin-producing islet cells, as well as our leadership role in the Vertex VX-880 clinical trial. Spearheaded in collaboration with DRI’s Dr. Camillo Ricordi, this first successful in-human transplant of stem cell-derived islets will ultimately help solve the challenge of developing an unlimited supply of insulin-producing cells. But there is still more progress to be made. Advancing continued cutting-edge research, led by scientific director Dr. Matthias von Herrath, is made possible by the generosity of donors. Every contribution brings us closer to the cure.


Donate Now

###

About the Diabetes Research Institute (DRI) and Foundation

The Diabetes Research Institute (DRI) and Foundation were created for one reason – to cure diabetes – which is and will continue to be the singular focus until that goal is reached. As one of the largest and most comprehensive research centers dedicated to curing diabetes, the DRI is working to restore natural insulin production and normalize blood sugar levels without imposing other risks. Researchers have already shown that transplanted insulin-producing islet cells allow people with type 1 diabetes to live without the need for insulin injections. Some of the DRI’s islet transplant patients have been free from insulin for more than 10 years. Funding provided by the Foundation is the driving force that allows DRI scientists to pursue new and innovative ideas, and to speed these discoveries to patients. The Diabetes Research Institute Foundation is the organization of choice for those who want to Be Part of the Cure. For more information, please visit DiabetesResearch.org or call 800-321-3437.

Keep Up With Our Progress Toward A Cure & More